Wang J P, Liu L, Liu X, Yang X Y, Li D, Ge G Q, Huang Q W
Department of Pharmacology, School of Pharmacy, Shanghai Medical University, China.
Zhongguo Yao Li Xue Bao. 1992 Jul;13(4):298-301.
The comparison between indomethacin conventional capsule (CC) po 25 mg q 8 h or 25 mg tid and indomethacin sustained-release capsule (SRC) po 25 mg bid in human by crossover design showed that both maximal serum concentration (Cmax) and fluctuation index (FI%) of SRC were significantly lower than those of CC during steady state (P < 0.01). No practical differences were observed between the 2 preparations in the trough serum concentration (Cmin) and area under serum concentration-time profiles (AUC0-tau) (P > 0.05). The time period reaching maximal serum concentration (Tmax) of SRC was much more delayed than that of CC (P < 0.01). It suggested that SRC possesses a better controlled release property and could avoid a higher serum peak concentration of CC.
采用交叉设计对人体口服25毫克吲哚美辛常规胶囊(CC)、每8小时一次或每日三次,与口服25毫克吲哚美辛缓释胶囊(SRC)、每日两次进行比较,结果显示,在稳态时,SRC的最大血清浓度(Cmax)和波动指数(FI%)均显著低于CC(P<0.01)。两种制剂在谷浓度(Cmin)和血清浓度-时间曲线下面积(AUC0-tau)方面未观察到实际差异(P>0.05)。SRC达到最大血清浓度的时间(Tmax)比CC延迟得多(P<0.01)。这表明SRC具有更好的控释性能,可避免CC的血清峰值浓度过高。